Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial

Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial

TP53 mutation is associated with cancer progression. Novel strategies to reboot p53 are required to stabilize the disease and improve survival. This randomized placebo-controlled trial investigated safety and efficacy of Nutri-PEITC Jelly (a texture-modified nutritious diet fortified with β-phenethy...

Full description

Bibliographic Details
Main Authors: Lam-Ubol, A. (Author), Rasio, W. (Author), Sukhaboon, J. (Author), Tangshewinsirikul, T. (Author), Trachootham, D. (Author), Tupwongse, P. (Author)
Format: Article
Language:English
Published: MDPI 2023
Subjects:
clinical trial
controlled study
cytochrome c
Cytochromes c
genetics
human
Humans
Nutri-Jelly
oral cancer
Oropharyngeal Neoplasms
oropharynx tumor
p53
PEITC
phenethyl isothiocyanate
progression free survival
Progression-Free Survival
protein p53
quality of life
Quality of Life
randomized controlled trial
survival
tertiary chemoprevention
Tumor Suppressor Protein p53
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items